Pharmacists can: Recognize hypoglycemia, help patients manage it, and encourage them to discuss measures with their prescriber to avoid itincluding the use of medications with lower risk of hypoglycemia Help patients achieve glycemic control by assisting with ideal medication choice and selecting an individualized, appropriate A1C target to optimize CV outcomes in diabetes Identify and mitigate causes of nonadherence to diabetes medications Recommend diabetes medications with the best evidence and FDA indications to improve CV outcomes in patients with or at elevated risk for CV disease, or in patients particularly wanting to minimize CV disease Conclusion Evidence has been building for many years in support of the vascular benefits provided by medications in the treatment of diabetes
Blood 114(22):820-21, 2009
Patients may experience increased fatigue, headaches, or brain fog during the initial phases of treatment
Dose escalation Mounjaro starts at 2.5 mg weekly, increasing by 2.5 mg every four weeks
Fountoulakis M, Mesa C, Schmid G, Gentz R, Manneberg M, Zulauf M et al
This is particularly beneficial for those who need an extra boost in their post-operative weight management journey
